1 A Low-Intensity Mobile Health Intervention With and Without Health Counseling for Persons With Type 2 Diabetes, Part 1: Baseline and Short-Term Results From a Randomized Controlled Trial in the Norwegian Part of RENEWING HEALTH

2 Evaluating the Effect of Web-Based Iranian Diabetic Personal Health Record App on Self-Care Status and Clinical Indicators: Randomized Controlled Trial

3 the effect of changing regular care provider in type 2 diabetes mellitus: a retrospective study

4 diabetes-related lower-extremity amputation incidence and risk factors: a prospective seven-year study in costa rica incidencia y factores de riesgo de la amputación de extremidades inferiores relacionada con la diabetes: estudio prospectivo de siete años en costa rica

5 effects of a 6-month exenatide therapy on hba1c and weight in korean patients with type 2 diabetes: a retrospective cohort study

6 correlation between the brachial-ankle pulse wave velocity and peripheral neuropathy in patients with type 2 diabetes

7 association of acanthosis nigricans and skin tags with insulin resistance associação de acantose nigricante e acrocórdons à resistência insulínica

8 quality of previous diabetes care among patients receiving services at ophthalmology hospitals in mexico calidad de la atención previa de los pacientes diabéticos atendidos en hospitales de oftalmología en méxico

9 oxidative dna damage in female patients with diabetes mellitus type 2.

10 elevated white blood cell count is associated with higher risk of glucose metabolism disorders in middle-aged and elderly chinese people

11 fatores relacionados ao autocuidado de pessoas com diabetes mellitus atendidas em serviço de urgência no méxico factores relacionados al autocuidado de personas con diabetes mellitus atendidas en servicio de urgencia en méxico factors related to self-care in diabetes mellitus patients attended at emergency service in mexico

12 pyruvate dehydrogenase kinases: therapeutic targets for diabetes and cancers

13 type 1 ig-e mediated allergy to human insulin, insulin analogues and beta-lactam antibiotics hipersensibilidade imediata a insulina humana, análogos de insulina e a antibióticos beta-lactâmicos

14 Calcium

15 Insulin-like growth factor I, binding proteins -1 and -3, risk of type 2 diabetes and macronutrient intakes in men.

16 Mushroom consumption, biomarkers, and risk of cardiovascular disease and type 2 diabetes: a prospective cohort study of US women and men.

17 Ertugliflozin for the treatment of type 2 diabetes.

18 Angiotensin II type 2 receptor blocker PD123319 has more beneficial effects than losartan on ischemia/reperfusion injury and oxidative damage in isolated rat heart.

19 The reliability of use of WhatsApp in type 1 and type 2 pediatric supracondylar fractures.

20 Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.

21 Glycaemic, weight, and blood pressure changes associated with early versus later treatment intensification with dapagliflozin in United Kingdom primary care patients with type 2 diabetes mellitus.

22 CONTROL SYSTEM DESIGN WITH FUZZY LOGIC PID-СONTROLLER TYPE 2

23 Molecular typing revealed the emergence of pvl-positive sequence type 22 methicillin-susceptible Staphylococcus aureus in Urumqi, Northwestern China

24 First-line Helicobacter pylori eradication rates are significantly lower in patients with than those without type 2 diabetes mellitus

25 Evidence-based approach for managing hypertension in type 2 diabetes

26 Optimal treatment of chronic angina in patients with type 2 diabetes mellitus

27 Cardiovascular protection in type 2 diabetes: time to ADVANCE management ACCORDing to the evidence

28 Molecular typing revealed the emergence of pvl-positive sequence type 22 methicillin-susceptible Staphylococcus aureus in Urumqi, Northwestern China

29 First-line Helicobacter pylori eradication rates are significantly lower in patients with than those without type 2 diabetes mellitus

30 Molecular typing revealed the emergence of pvl-positive sequence type 22 methicillin-susceptible Staphylococcus aureus in Urumqi, Northwestern China

31 First-line Helicobacter pylori eradication rates are significantly lower in patients with than those without type 2 diabetes mellitus

32 Evidence-based approach for managing hypertension in type 2 diabetes

33 Fresh Pomegranate Juice Decreases Fasting Serum Erythropoietin in Patients with Type 2 Diabetes

34 Improvement in Glycemic and Lipid Profiles in Type 2 Diabetics with a 90-Day Ketogenic Diet

35 Optimal treatment of chronic angina in patients with type 2 diabetes mellitus

36 Cardiovascular protection in type 2 diabetes: time to ADVANCE management ACCORDing to the evidence

37 Predictors of isolated systolic hypertension among type 2 diabetes mellitus patients in Jimma University Specialized Hospital, Southwest Ethiopia.

38 Relationship between dietary non-enzymatic antioxidant capacity and type 2 diabetes risk in the Japan Public Health Center-based Prospective Study

39 Instrumental Acoustic Voice Characteristics in Adults with Type 2 Diabetes.

40 Prevalence of urinary incontinence in males with type 2 diabetes mellitus.

41 Real-world evidence of glycemic control among patients with type 2 diabetes mellitus in India: the TIGHT study.

42 The Triglyceride/HDL Ratio and Triglyceride Glucose Index as Predictors of Glycemic Control in Patients with Diabetes Mellitus Type 2.

43 Effect of Linagliptin on Cognitive Performance in Patients With Type 2 Diabetes and Cardiorenal Comorbidities: The CARMELINA Randomized Trial.

44 Comparison of HbA1c levels and body mass index for prevention of diabetic kidney disease: A retrospective longitudinal study using outpatient clinical data in Japanese patients with type 2 diabetes mellitus.

45 Personalized intervention to improve stress and sleep patterns for glycemic control and weight management in obese Emirati patients with type 2 diabetes: a randomized controlled clinical trial.

46 Poor sleep quality and its predictors among type 2 diabetes mellitus patients attending Jimma University Medical Center, Jimma, Ethiopia.

47 Effect of scaling and root planing on serum interleukin-10 levels and glycemic control in chronic periodontitis and type 2 diabetes mellitus

48 Effectiveness of gliclazide MR 60 mg in the management of type 2 diabetes: analyses from the EASYDia trial

49 Glycemic variability in continuous glucose monitoring is inversely associated with baroreflex sensitivity in type 2 diabetes: a preliminary report

50 Evaluation of fixed dose combination of glimepiride and metformin in patients with type 2 diabetes. Results of Russian observational study

51 Effect of Linagliptin and Voglibose on metabolic profile in patients with Type 2 Diabetes: a randomized, double-blind, placebo-controlled trial

52 Follow-up of glycemic index before and after Ramadan fasting in type 2 diabetes patients under antidiabetic medications

53 Effect of baseline body mass index on glycemic control and weight change with exenatide monotherapy in Chinese drug-naïve type 2 diabetic patients

54 Dietary glycemic index and load and the risk of type 2 diabetes: Assessment of causal relations

55 Beneficial effects of green cardamom on serum SIRT1, glycemic indices and triglyceride levels in patients with type 2 diabetes mellitus: a randomized double-blind placebo controlled clinical trial

56 Correction to: Beyond HbA1c: Comparing glycemic variability and glycemic indices in predicting hypoglycemia in Type 1 and Type 2 diabetes (Diabetes Technology and Therapeutics (2018) 20:5 (353-362) DOI: 10.1089/dia.2017.0388)

57 Insulin Glargine U100 Improved Glycemic Control and Reduced Nocturnal Hypoglycemia in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease Stages 3 and 4.

58 Clinical Characteristics and Glycemic Outcomes of Patients with Type 2 Diabetes Requiring Maximum Dose Insulin Glargine/Lixisenatide Fixed-Ratio Combination or Insulin Glargine in the LixiLan-L Trial.

59 Cholecalciferol improves glycemic control in type 2 diabetic patients: a 6-month prospective interventional study

60 Short height and poor education increase the risk of dementia in Nigerian type 2 diabetic women.

61 2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea.

62 Body Mass Index: A Risk Factor for Retinopathy in Type 2 Diabetic Patients

63 Challenges and Opportunities Associated with Incorporating New Evidence of Drug-Mediated Cardioprotection in the Economic Modeling of Type 2 Diabetes: A Literature Review.

64 Effect of 'lifestyle stigma' on public support for NHS-provisioned pre-exposure prophylaxis (PrEP) and preventative interventions for HPV and type 2 diabetes: a nationwide UK survey.

65 Genetic association of insulin receptor substrate-1 (IRS-1, rs1801278) gene with insulin resistant of type 2 diabetes mellitus in a Pakistani population.

66 The Prevalence and Impact of Low Faecal Elastase-1 in Community-Based Patients with Type 2 Diabetes.

67 Patient Reported Outcomes Following Initiation of Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes in a Specialist Endocrinology Practice of the LMC Diabetes Registry: The PROGRESS-Diabetes Study.

68 Evaluation of Nutritional Status and Allostatic Load in Adult Patients With Type 2 Diabetes.

69 Association of famine exposure with the risk of type 2 diabetes: A meta-analysis.

70 Effect of Empagliflozin on Free Fatty Acids and Ketone Bodies in Japanese Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial.

71 The association between type 2 diabetes mellitus, hip fracture, and post-hip fracture mortality: a multi-state cohort analysis.

72 The possible synergistic action of sex hormones and glucagon-like peptide-1 (GLP-1) agonists on body mass decline in patients with type 2 diabetes mellitus.

73 Challenges to diabetes self-management for adults with type 2 diabetes in low-resource settings in Mexico City: a qualitative descriptive study.

74 Predictors of loss to follow up among patients with type 2 diabetes mellitus attending a private not for profit urban diabetes clinic in Uganda - a descriptive retrospective study.

75 The Effect of Diabetes-Specific Enteral Nutrition Formula on Cardiometabolic Parameters in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.

76 Boswellic extracts and 11-keto-ß-boswellic acids prevent type 1 and type 2 diabetes mellitus by suppressing the expression of proinflammatory cytokines

77 Upregulation of SCUBE2 expression in dyslipidemic type 2 diabetes mellitus is associated with endothelin-1

78 Xenobiotic mediated diabetogenesis: Developmental exposure to dichlorvos or atrazine leads to type 1 or type 2 diabetes in Drosophila

79 Initial injectable therapy in type 2 diabetes: Key considerations when choosing between glucagon-like peptide 1 receptor agonists and insulin

80 Locally delivered GLP-1 analogues liraglutide and exenatide enhance microvascular perfusion in individuals with and without type 2 diabetes

81 Association of genetic variants in IGF-1 gene with susceptibility to gestational and type 2 diabetes mellitus

82 The Influence of Type 2 Diabetes-Associated Factors on Type 1 Diabetes

83 Diabetes Canada Position Statement on Recreational Cannabis Use in Adults and Adolescents With Type 1 and Type 2 Diabetes

84 Glucagon-Like Peptide-1 Receptor Analogues in Type 2 Diabetes: Their Use and Differential Features

85 The good companions: insulin and glucagon-like peptide-1 receptor agonist in type 2 diabetes. A systematic review and meta-analysis of randomized controlled trials

86 Association of urinary monocyte chemoattractant protein-1 (MCP-1) and kidney injury molecule-1 (KIM-1) with risk factors of diabetic kidney disease in type 2 diabetes patients

87 GLP-1 Receptor Agonists for Type 2 Diabetes and Their Role in Primary Care: An Australian Perspective

88 Comorbid elevated symptoms of anxiety and depression in adults with type 1 or type 2 diabetes: Results from the International Diabetes MILES Study

89 Prevalence of type 1 and type 2 diabetes among US pediatric population in the MarketScan Multi-State Database, 2002 to 2016

90 Rs12778366 single nucleotide polymorphism of Sirtuin 1 (SIRT1) and response to resveratrol supplementation in patients with type 2 diabetes mellitus

91 Enhancing Health Surveillance: Validation of a Novel Electronic Medical Records-Based Definition of Cases of Pediatric Type 1 and Type 2 Diabetes Mellitus

92 Elevated expression of ICAM-1 in synovium is associated with early inflammatory response for cartilage degeneration in type 2 diabetes mellitus

93 Leisure time physical activity is associated with better metabolic control in adults with type 1 and type 2 diabetes mellitus: A cross-sectional study from two public hospitals in Chile

94 Increased formation of neutrophil extracellular traps is associated with gut leakage in patients with type 1 but not type 2 diabetes

95 Cost effectiveness of vildagliptin versus glimepiride as add-on treatment to metformin for the treatment of diabetes mellitus type 2 patients in Greece

96 Regenerating 1 and 3b gene expression in the pancreas of type 2 diabetic Goto-Kakizaki (GK) rats.

97 Comparison of rosuvastatin and atorvastatin for lipid lowering in patients with type 2 diabetes mellitus: results from the URANUS study

98 Nuclear NF-κB p65 in peripheral blood mononuclear cells correlates with urinary MCP-1, RANTES and the severity of type 2 diabetic nephropathy.

99 Health information, behavior change, and decision support for patients with type 2 diabetes: development of a tailored, preference-sensitive health communication application

100 Genes associated with free fatty acid levels and dyslipidemia in type 2 diabetes patients

101 Linking type 2 diabetes mellitus, cardiac hypertrophy and depression in a diurnal animal model

Keyword Connections

Journals

Research Groups

Bibliographies